Resultados financieros en millones de dólares estadounidenses. El ejercicio fiscal es febrero - enero.
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Ingresos
3,436
3,436
3,366
2,964
2,530
2,417
Crecimiento de los Ingresos (YoY)
2%
2%
14%
17%
5%
22%
Costo de los ingresos
1,831
1,858
1,705
1,447
1,224
1,208
Utilidad bruta
1,604
1,577
1,661
1,516
1,306
1,209
Venta, General y Administración
946
946
893
730
609
562
Investigación y Desarrollo
395
395
376
294
235
220
Gastos de Operación
1,373
1,413
1,274
1,030
846
783
Otras Ingresos (Gastos) No Operativos
4
--
1
0
-1
-2
Ingreso antes de impuestos
22
22
206
544
413
393
Gasto por Impuesto a la Renta
29
29
91
117
116
113
Ingreso Neto
-22
-22
113
427
296
277
Crecimiento de la Utilidad Neta
-119%
-119%
-74%
44%
7%
76%
Acciones en Circulación (Diluidas)
152.5
151.8
149.5
147.2
149.4
152.9
Cambio de Acciones (YoY)
0%
2%
2%
-1%
-2%
-1%
EPS (Diluido)
-0.14
-0.14
0.75
2.9
1.99
1.81
Crecimiento de EPS
-120%
-120%
-74%
46%
10%
77%
Flujo de efectivo libre
13
13
136
243
145
190
Flujo de efectivo libre por acción
--
--
--
--
--
--
Margen bruto
46.68%
45.89%
49.34%
51.14%
51.62%
50.02%
Margen de operación
6.72%
4.77%
11.49%
16.39%
18.18%
17.62%
Margen de beneficio
-0.64%
-0.64%
3.35%
14.4%
11.69%
11.46%
Margen de flujo de caja libre
0.37%
0.37%
4.04%
8.19%
5.73%
7.86%
EBITDA
451
384
570
600
548
515
Margen de EBITDA
13.12%
11.17%
16.93%
20.24%
21.66%
21.3%
D&A para EBITDA
220
220
183
114
88
89
EBIT
231
164
387
486
460
426
Margen de EBIT
6.72%
4.77%
11.49%
16.39%
18.18%
17.62%
Tasa de Impuesto Efectiva
131.81%
131.81%
44.17%
21.5%
28.08%
28.75%
360Informe
Estadísticas clave
Cierre Anterior
$36.51
Precio de apertura
$36.78
Rango del día
$36.66 - $38.33
Rango de 52 semanas
$28.53 - $56.22
Volumen
3.5M
Volumen promedio
2.3M
EPS (TTM)
-0.14
Rendimiento de dividendos
0.34%
Cap. de mercado
$5.8B
¿Qué es BRKR?
Bruker Corp. engages in the business of developing, manufacturing, and distributing high-performance scientific instruments and analytical and diagnostic solutions that enable customers to explore life and materials at microscopic, molecular, and cellular levels. The company is headquartered in Billerica, Massachusetts and currently employs 11,396 full-time employees. The company went IPO on 2000-08-04. Its segments include Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI NANO, and Bruker Energy & Supercon Technologies (BEST). BSI segment designs, manufactures and distributes life science tools based on magnetic resonance technology and offers automated laboratory research. BSI CALID segment designs, manufactures and distributes life science mass spectrometry, applied spectrometry and ion mobility spectrometry solutions, analytical and process analysis instruments and solutions. BSI NANO designs, manufactures and distributes advanced x-ray instruments, atomic force microscopy instrumentation, and fluorescence optical microscopy instruments. BEST segment develops and manufactures superconducting and non-superconducting materials and devices for use in renewable energy, energy infrastructure, healthcare and energy physics research.